haematology
Coagulation

Dabigatran reviewed for liver injury

A safety review by Health Canada has concluded there may be a link between dabigatran (Pradaxa) and liver injury. The review, triggered by reports of severe liver injury in 27 patients, found three cases, including one death, ‘showed a possible link between liver injury and the use of Pradaxa’. However the review said there was ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic